FDA Peptide Vote 2026: BPC-157, TB-500, KPV, MOTS-c, Epitalon & Semax Recommended — What Happens Next

The FDA's compounding advisory committee recommended six peptides and rejected DSIP. Here are the vote counts, why FDA staff opposed them, the rulemaking timeline, and the lab research behind each compound.